(NEW YORK)Canadian drugmaker Biovail Corp. said Wednesday it is seeking U.S. approval to market a generic version of a blockbuster cholesterol drug from Abbott Laboratories.READ MORE
(NEW YORK)Drugmaker Biovail said Monday that Canadian health regulators have expanded use of its pain medication Ralivia. The Canadian pharmaceutical firm said the once-a-day pill is now app...READ MORE
(NEW YORK)Canadian drug developer Biovail Corp. said Thursday it named Peggy Mulligan chief financial officer, effective Sept. 3. She replaces Adrian A. De Saldanha, who had been serving as ...READ MORE
Among the earnings stories for Wednesday, Aug. 13, from AP Financial News: AMSTERDAM, Netherlands (AP)--ING Groep NV, the Dutch insurer and bank, said Wednesday its second quarter ...READ MORE
(NEW YORK)Canadian drug developer Biovail Corp. said Wednesday it swung to a loss in the second quarter, weighed down by declining revenue and charges related to its shift in focus to centra...READ MORE
(NEW YORK)Canadian drug developer Biovail Corp. on Wednesday said its board of directors set a regular quarterly dividend of 37.5 cents. The dividend is payable Sept. 3 to shareholders of re...READ MORE
(NEW YORK)Canadian drugmaker Biovail Corporation said Thursday it has extended the deadline for shareholders to vote on issues to be discussed at its reconvened annual meeting.READ MORE